{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Implementing Page Rank on Phenotype-GARD disease graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "from py2neo import Graph\n",
    "from py2neo import Node"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from matplotlib import pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "from py2neo import Database\n",
    "db = Database(\"bolt://disease.ncats.io:80\")\n",
    "graph = db.default_graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "#get networkx subset\n",
    "#use networkx page rank algo"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "query = \"\"\"match (n:S_GARD)--(d:DATA) where d.id = 5 with n,d \n",
    "        match p=(n)-[R_rel{name:'has_phenotype'}]-\n",
    "        (:S_HP)--(:DATA) return p,d\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0001252', `HPO-term-name`: 'Muscular hypotonia', created: 1591077694718, diseaseId: 'ORPHA:14', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0001252'}]->(_66781)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0001252', source: 'd7a8dc9fd'}]-(_66782) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0002024', `HPO-term-name`: 'Malabsorption', created: 1591077694705, diseaseId: 'ORPHA:14', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0002024'}]->(_84944)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0002024', source: 'd7a8dc9fd'}]-(_84945) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0007703', `HPO-term-name`: 'Abnormality of retinal pigmentation', created: 1591077694692, diseaseId: 'ORPHA:14', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0007703'}]->(_57088)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0007703', source: 'd7a8dc9fd'}]-(_57089) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0001315', `HPO-term-name`: 'Reduced tendon reflexes', created: 1591077694667, diseaseId: 'ORPHA:14', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0001315'}]->(_100668)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0001315', source: 'd7a8dc9fd'}]-(_100669) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0000505', `HPO-term-name`: 'Visual impairment', created: 1591077694638, diseaseId: 'ORPHA:14', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0000505'}]->(_83574)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0000505', source: 'd7a8dc9fd'}]-(_83575) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0001251', `HPO-term-name`: 'Ataxia', created: 1591072667758, diseaseId: ['OMIM:200100', 'ORPHA:14'], `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0001251'}]->(_66789)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0001251', source: 'd7a8dc9fd'}]-(_66790) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0008181', `HPO-term-name`: 'Abetalipoproteinemia', created: 1591072667722, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0008181'}]->(_12810)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0008181', source: 'd7a8dc9fd'}]-(_26115) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0000488', `HPO-term-name`: 'Retinopathy', created: 1591072667684, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0000488'}]->(_50188)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0000488', source: 'd7a8dc9fd'}]-(_50189) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0001927', `HPO-term-name`: 'Acanthocytosis', created: 1591072667616, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0001927'}]->(_24034)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0001927', source: 'd7a8dc9fd'}]-(_30855) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0000546', `HPO-term-name`: 'Retinal degeneration', created: 1591072667581, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0000546'}]->(_82374)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0000546', source: 'd7a8dc9fd'}]-(_82375) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0002630', `HPO-term-name`: 'Fat malabsorption', created: 1591072667542, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0002630'}]->(_69462)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0002630', source: 'd7a8dc9fd'}]-(_69463) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0011096', `HPO-term-name`: 'Peripheral demyelination', created: 1591072667471, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0011096'}]->(_81909)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0011096', source: 'd7a8dc9fd'}]-(_81910) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0007305', `HPO-term-name`: 'CNS demyelination', created: 1591072667404, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0007305'}]->(_101583)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0007305', source: 'd7a8dc9fd'}]-(_101584) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n",
      "<Record p=(_7)-[:R_rel {`HPO-ID`: 'HP:0000007', `HPO-term-name`: 'Autosomal recessive inheritance', created: 1591072667333, diseaseId: 'OMIM:200100', `gene-id(entrez)`: '4547', `gene-symbol`: 'MTTP', name: 'has_phenotype', source: 'a8cf83e5f', value: 'HP:0000007'}]->(_89585)<-[:PAYLOAD {id: 'http://purl.obolibrary.org/obo/HP_0000007', source: 'd7a8dc9fd'}]-(_89586) d=(_8:DATA {Cause: 'Abetalipoproteinemia is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/MTTP\" target=\"_blank\"><em>MTTP</em></a> gene. The <em>MTTP</em> gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> needed for creating beta-lipoproteins. These lipoproteins are necessary for the body to absorb fats, cholesterol, and fat-soluble vitamins (vitamins A,&nbsp;D, E and K), and for transporting these substances&nbsp;in the blood. Mutations in the <em>MTTP</em>&nbsp;result in a lack of beta-lipoproteins, leading to an inability to absorb and transport these substances. This in turn leads to the nutritional and neurologic problems&nbsp;in affected people.[5103]', Diagnosis: 'The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0000744/\" target=\"_blank\">Genetic Testing Registry</a> (GTR) provides information about the genetic tests available for abetalipoproteinemia. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\\r\\n<br />\\r\\nPrenatal testing may be available for pregnancies at increased risk if the mutations in the family have been identified.<br />', HPO: ['HP:0000505', 'HP:0002024', 'HP:0007703', 'HP:0001315', 'HP:0001251', 'HP:0001252', 'HP:0000488', 'HP:0002630', 'HP:0007305', 'HP:0000007', 'HP:0008181', 'HP:0011096', 'HP:0000546', 'HP:0001927'], Inheritance: 'Abetalipoproteinemia&nbsp;is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[10991] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\\r\\n<ul>\\r\\n    <li>25% (1 in 4) chance to be affected</li>\\r\\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\\r\\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\\r\\n</ul>', Prognosis: 'The long-term outlook (prognosis) is reasonably good for most people who are diagnosed and treated early.[10989] However, how well each person does depends on the amount of brain and nervous system problems.[1021] Therefore, the prognosis can vary.[10990] People with prolonged vitamin deficiency, especially of vitamin E, may develop very limiting ataxia and gait disturbances.&nbsp;Some people may develop retinal degeneration and blindness.[10989]', Symptoms: 'The signs and symptoms of abetalipoproteinemia usually appear in the first few months of life. They can include:<br />\\r\\n<ul>\\r\\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=\"_blank\">failure to thrive</a> in infancy</li>\\r\\n    <li>digestive symptoms such as diarrhea and steatorrhea (foul-smelling stools)</li>\\r\\n    <li>abnormal, star-shaped red blood cells (<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10284/Acanthocytosis.aspx\" target=\"_blank\">acanthocytosis</a>)</li>\\r\\n    <li>nervous system (neurologic) symptoms beginning in childhood such as slower intellectual development; peripheral neuropathy; poor muscle coordination; <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>; and intention <a href=\"http://www.ninds.nih.gov/disorders/tremor/detail_tremor.htm\" target=\"_blank\">tremors</a></li>\\r\\n    <li>eye (ophthalmologic) symptoms such as decreased night and color vision; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\">retinitis pigmentosa</a> in adolescence; and gradual deterioration of vision, often leading to blindness in the fourth decade of life[5103][10989]</li>\\r\\n</ul>', Treatment: 'A nutritionist or other qualified medical professional should be consulted for&nbsp;specific dietary instruction in people with abetalipoproteinemia. Treatment involves very large doses of vitamin E, as well as large doses of vitamin supplements containing other fat-soluble vitamins (vitamin A, vitamin D, and vitamin K). Linoleic acid supplements  are also recommended.[1021][10989]<br />\\r\\n<br />\\r\\nSeveral diet changes and/or restrictions are also needed to prevent stomach problems. A low-fat diet may help with digestive symptoms; medium chain triglycerides may be used (under supervision of a specialist) as a source of fat in the diet.[1021]<br />\\r\\n<br />\\r\\nManagement in adults typically focuses on specific complications associated with the disorder, and depends on the signs and symptoms present. Affected people may need consultations with several other types of specialists, including a lipidologist, gastroenterologist, hepatologist, ophthalmologist, and neurologist.[10989]', categories: ['Metabolic disorders', 'Digestive Diseases', 'Nervous System Diseases', 'Eye diseases', 'Endocrine Diseases', 'Blood Diseases', 'Congenital and Genetic Diseases'], created: 1588206395363, gard_id: 'GARD:0000005', id: 5, is_rare: true, name: 'Abetalipoproteinemia', parents: 2876, synonyms: ['Bassen Kornzweig syndrome', 'Microsomal triglyceride transfer protein deficiency disease', 'Microsomal triglyceride transfer protein deficiency', 'ABL', 'Abetalipoproteinemia neuropathy', 'Apolipoprotein B deficiency', 'Betalipoprotein deficiency disease', 'Congenital betalipoprotein deficiency syndrome', 'MTP deficiency', 'Bassen-Kornzweig disease', 'Homozygous familial hypobetalipoproteinemia'], uri: 'http://purl.obolibrary.org/obo/GARD_0000005', xrefs: ['OMIM:200100', 'ORPHA:14', 'ORPHANET:14']})>\n"
     ]
    }
   ],
   "source": [
    "cursor = graph.run(query)\n",
    "\n",
    "#print the records from the Database.cursor object\n",
    "for record in cursor:\n",
    "    print(record)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "from neo4j import GraphDatabase\n",
    "from neo4j.types.graph import Node, Relationship\n",
    "import pandas as pd\n",
    "import networkx as nx"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "def graph_from_cypher(data):\n",
    "    \"\"\"Constructs a networkx graph from the results of a neo4j cypher query.\n",
    "    Example of use:\n",
    "    >>> result = session.run(query)\n",
    "    >>> G = graph_from_cypher(result.data())\n",
    "\n",
    "    Nodes have fields 'labels' (frozenset) and 'properties' (dicts). Node IDs correspond to the neo4j graph.\n",
    "    Edges have fields 'type_' (string) denoting the type of relation, and 'properties' (dict).\"\"\"\n",
    "\n",
    "    G = nx.MultiDiGraph()\n",
    "    def add_node(node):\n",
    "        # Adds node id it hasn't already been added\n",
    "        u = node.id\n",
    "        if G.has_node(u):\n",
    "            return\n",
    "        G.add_node(u, labels=node._labels, properties=dict(node))\n",
    "\n",
    "    def add_edge(relation):\n",
    "        # Adds edge if it hasn't already been added.\n",
    "        # Make sure the nodes at both ends are created\n",
    "        for node in (relation.start_node, relation.end_node):\n",
    "            add_node(node)\n",
    "        # Check if edge already exists\n",
    "        u = relation.start_node.id\n",
    "        v = relation.end_node.id\n",
    "        eid = relation.id\n",
    "        if G.has_edge(u, v, key=eid):\n",
    "            return\n",
    "        # If not, create it\n",
    "        G.add_edge(u, v, key=eid, type_=relation.type, properties=dict(relation))\n",
    "\n",
    "    for d in data:\n",
    "        for entry in d.values():\n",
    "            # Parse node\n",
    "            if isinstance(entry, Node):\n",
    "                add_node(entry)\n",
    "                print(\"node\")\n",
    "\n",
    "            # Parse link\n",
    "            elif isinstance(entry, Relationship):\n",
    "                add_edge(entry)\n",
    "                print(\"edge\")\n",
    "            else:\n",
    "                raise TypeError(\"Unrecognized object\")\n",
    "    return G"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "driver = GraphDatabase.driver(\"bolt://disease.ncats.io:80\", auth=(\"neo4j\", \"\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 1min 43s, sys: 4.2 s, total: 1min 47s\n",
      "Wall time: 2h 15min 50s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "query = \"\"\"match r=(d:DATA)--(n:S_GARD)-[:R_rel{name:\"has_phenotype\"}]-(p:S_HP)--(b:DATA) return *\"\"\"\n",
    "\n",
    "with driver.session() as session:\n",
    "    result = session.run(query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%time\n",
    "query = \"\"\"match (n:S_GARD)--(d:DATA) with n,d match r=(n)-[:R_rel{name:\"has_phenotype\"}]-(p:S_HP)--(b:DATA) \n",
    "        return r,d,b\"\"\"\n",
    "\n",
    "with driver.session() as session:\n",
    "    result = session.run(query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "Unrecognized object",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-39-4a90a6597bc5>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mgraph\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgraph_from_cypher\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mresult\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;32m<ipython-input-14-e3f8abfbc02e>\u001b[0m in \u001b[0;36mgraph_from_cypher\u001b[0;34m(data)\u001b[0m\n\u001b[1;32m     40\u001b[0m                 \u001b[0madd_edge\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mentry\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     41\u001b[0m             \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 42\u001b[0;31m                 \u001b[0;32mraise\u001b[0m \u001b[0mTypeError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"Unrecognized object\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     43\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mG\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mTypeError\u001b[0m: Unrecognized object"
     ]
    }
   ],
   "source": [
    "graph = graph_from_cypher(result.data())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "graph2 = graph_from_cypher(result.data())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "graph2.number_of_nodes()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: \n",
      "Type: MultiDiGraph\n",
      "Number of nodes: 0\n",
      "Number of edges: 0\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(nx.info(graph))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<neo4j.BoltStatementResult at 0xa338262b0>"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result.da"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
